Percutaneous coronary intervention for small vessel coronary artery disease

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Symptomatic coronary artery disease often involves small caliber coronary vessels (<2.75 mm).
• Revascularization via percutaneous coronary intervention (PCI) or bypass surgery is considered when medical therapy fails.
• PCI in small vessels carries a significant risk of midterm restenosis, even with modern devices.

Purpose of the Study:

• To review percutaneous coronary revascularization strategies for small vessel coronary artery disease.
• To highlight the role of drug-eluting stents in improving outcomes.
• To provide an updated perspective on managing these complex cases.

Main Methods:

• Review of current literature on percutaneous coronary intervention for small coronary vessels.
• Analysis of outcomes associated with different PCI techniques and stent types.
• Focus on angiographic and clinical results, particularly restenosis rates.

Main Results:

• Drug-eluting stents demonstrate improved angiographic and clinical outcomes compared to balloon-only PCI or bare-metal stents.
• Very low late lumen loss (<0.20 mm) with drug-eluting stents is associated with better results.
• Despite advancements, small vessel PCI remains associated with a notable risk of restenosis.

Conclusions:

• Drug-eluting stents are crucial for improving outcomes in percutaneous coronary intervention for small vessel coronary artery disease.
• Careful selection of devices and techniques is essential to mitigate restenosis risk.
• Further research and technological advancements are needed for optimal management.